| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/10/2005 | WO2003030624A3 Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof |
| 02/10/2005 | WO2003025117A3 Cloning and sequencing of pyruvate decarboxylase (pdc) genes from bacteria and uses therefor |
| 02/10/2005 | WO2002064626A3 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 02/10/2005 | WO2002020718A3 Osteoclast-associated receptor |
| 02/10/2005 | US20050034199 Transgenic seed for propagation of insect resistance, herbicide resistance and disease resistance plants |
| 02/10/2005 | US20050034198 Inbred corn line G0302 |
| 02/10/2005 | US20050034196 Novel salicylic acid-binding protein encoding nucleic acid, SABP2, and methods of use thereof |
| 02/10/2005 | US20050034195 Expression vector comprising nucleotide sequences associated with coat specific expression of heterologous gene sequences; modifying seed caot luster |
| 02/10/2005 | US20050034194 Gene controlling flowering time of plants and method for manipulating flowering time of plant using the same |
| 02/10/2005 | US20050034193 Transcriptional activator nucleic acids, polypeptides and methods of use thereof |
| 02/10/2005 | US20050034192 Expression vector comprising tissue specific regulatory sequences for use tool in controlling heterologous gene expression in plants; generating insect resistant plants |
| 02/10/2005 | US20050034191 Transgenic canola seeds comprising sodium/proton exchange protein nucleotide sequences for use in generating/propagating plants with enhanced salt resistance |
| 02/10/2005 | US20050034190 Transgenic soybean seeds exhibiting an oil composition comprising 55 to 80% by weight oleic acid, 10 to 40% by weight linoleic acid, 6% or less by weight linolenic acid, and 2 to 8% by weight saturated fatty acids for use in ehancing applicability in food, biodiesel and biolube markets |
| 02/10/2005 | US20050034189 Expression vector comprising nucleotide sequences coding scarecrow like gene for use in transformation and generation of disease-resistant recombinant crops |
| 02/10/2005 | US20050034188 Refined plant transformation |
| 02/10/2005 | US20050034187 Modified tet-inducible system for regulation of gene expression in plants |
| 02/10/2005 | US20050034186 Site specific nucleic acid integration |
| 02/10/2005 | US20050034185 Melanocortin-3 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight |
| 02/10/2005 | US20050034183 Non-human animal model for analysis of the original and therapy of organ fibrosis |
| 02/10/2005 | US20050034182 Transgenic mouse with genome DNA sequence encoding a mutated human tau protein linked to promoter; mouse brain exhibits neurofibrillary tangles; Alzheimer*s and neurodegenerative disease |
| 02/10/2005 | US20050034181 Unactivated oocytes as cytoplast recipients for nuclear transfer |
| 02/10/2005 | US20050034180 Animal integration vector and methods for its use |
| 02/10/2005 | US20050034179 Transgenic animal cell which express tumor necrosis factor receptor for use in identifying agents for treatment of diabetes and inflammatory bowel disease |
| 02/10/2005 | US20050034177 Genetic modification of male germ cells for generation of transgenic species & genetic therapies |
| 02/10/2005 | US20050034175 Immune cloning and uses thereof |
| 02/10/2005 | US20050033524 Identification of genetic targets for modulation by oligonucleotides and generation of oligonucleotides for gene modulation |
| 02/10/2005 | US20050033042 Nucleic acids encoding recominant 56 and 82 kda antigens fromn gametocytes of eimeria maxima and their uses |
| 02/10/2005 | US20050033036 An isolated DNA encoding a protein, has testicular differentiation activity |
| 02/10/2005 | US20050033035 Mutants of igf binding proteins and methods of production of antagonists thereof |
| 02/10/2005 | US20050033031 Methods for humanizing rabbit monoclonal antibodies |
| 02/10/2005 | US20050033028 Reducing immunogenicities of immunoglobulins by framework-patching |
| 02/10/2005 | US20050033026 Immunoconjugates for the treatment of tumours |
| 02/10/2005 | US20050033025 Human papilloma viral proteins fragments for use in generating immunoglobullins for treatment and prevention infection; immunotherapeutics and diagnostice; viricides |
| 02/10/2005 | US20050033024 Expression vector comprising nucleotide sequences coding cytokine receptor for use as tool in identifying modulators for prevention and treatment allergic, skin and respiratory disorders |
| 02/10/2005 | US20050033019 Nucleotide sequence coding for a modified protein of interest, expression vector and method for obtaining same |
| 02/10/2005 | US20050033018 Receptors and membrane-associated proteins |
| 02/10/2005 | US20050033017 Nucleotide sequences coding receptor for advanced glycation endproducts (RAGE) for identifying modulators for treatment and prevention of cell proliferative and cardiovascular disorders |
| 02/10/2005 | US20050032978 Copolymer of isobutylene with carbamate groups which is curable |
| 02/10/2005 | US20050032736 Immunostimulatory nucleic acid molecules |
| 02/10/2005 | US20050032734 Vectors and methods for immunization or therapeutic protocols |
| 02/10/2005 | US20050032733 siNA molecule comprising a double-stranded structure that down-regulates expression of Hepatitis B Virus (HBV) , wherein said siNA molecule does not require the presence of nucleotides having a 2'-hydroxy group within the siNA molecule for mediating RNA interference |
| 02/10/2005 | US20050032730 Pharmaceutical composition containing a stabilised mRNA optimised for translation in its coding regions |
| 02/10/2005 | US20050032728 Tumor suppression through bicistronic co-expression of p53 and p14ARF |
| 02/10/2005 | US20050032727 Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways |
| 02/10/2005 | US20050032726 Protein kinase (PK); for increasing the susceptibility of a cell to DNA-damaging agents via hybridization of nucleic acids encoding DNA dependent protein kinases, preventing gene expression; genetic engineering |
| 02/10/2005 | US20050032724 Multidrug Resistance Protein 1 (MRP1); mutagenesis |
| 02/10/2005 | US20050032723 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals |
| 02/10/2005 | US20050032722 Soluble steroidal peptides for nucleic acid delivery |
| 02/10/2005 | US20050032714 immunotherapeutic for therapy and prophylaxis of cancer; reduced duration, less toxicity, and as thus results in improved tolerance |
| 02/10/2005 | US20050032704 Neural thread proteins (NTP); antiproliferative agents |
| 02/10/2005 | US20050032696 Muscle transcription factors |
| 02/10/2005 | US20050032694 Neurotrypsin |
| 02/10/2005 | US20050032693 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
| 02/10/2005 | US20050032692 Methods of inhibiting tumor cell proliferation |
| 02/10/2005 | US20050032681 Human antithrombin iiis and methods related thereto |
| 02/10/2005 | US20050032223 Generating site directed DNA breaks in transformed cells via expression of heterologous endonuclease; bioreactor for generating exogenous proteins; gene therapy |
| 02/10/2005 | US20050032220 Amplifiable adeno-associated virus (AAV) packaging cassettes for the production of recombinant AAV vectors |
| 02/10/2005 | US20050032219 Methods of administering vectors to synaptically connected neurons |
| 02/10/2005 | US20050032217 Transforming lymphocytes with vector comprising gene sequences which code cytolethal distending toxin (cdt), leukotoxins and heat shock protein and generating regulatory cell which can be used to treat and/or prevent transplant rejection, autoimmune and inflammatory diseases; immunotherapy |
| 02/10/2005 | US20050032216 Plasmid comprising antibody specific for cell surface membrane protein receptor (5T4) for use in tissue directed treatment of tumors; tissue targeted therapy |
| 02/10/2005 | US20050032215 Targeted introduction of DNA into primary or secondary cells and their use for gene therapy and protein production |
| 02/10/2005 | US20050032214 Cell-specific expression/replication vector |
| 02/10/2005 | US20050032213 Expression vector comprising polynucleotide which codes conditionally-inducible oncogene operably linked to enhancer of a nestin intron for use in prevention and treatment of disease associated with cell loss and/or damage |
| 02/10/2005 | US20050032212 Using pressurization and depressurization to increase permebility of cel wall; cell transformation and exogenous gene transfer |
| 02/10/2005 | US20050032208 Materials and methods to produce stem cells |
| 02/10/2005 | US20050032207 Method for isolating, culturing and differentiating intestinal stem cells for therapeutic use |
| 02/10/2005 | US20050032195 Actinobacillus succinogenes shuttle vector and methods of use |
| 02/10/2005 | US20050032194 Protease deficient caulobacter host cells |
| 02/10/2005 | US20050032191 Method for production of S-hydroxynitrile lyase by use of escherichia coli |
| 02/10/2005 | US20050032189 Novel protein derived from agkistrodon saxatilis emelianov and process preparing the same |
| 02/10/2005 | US20050032188 Construction of bacillus licheniformis T1 strain, and fermentation production of crude enzyme extract therefrom |
| 02/10/2005 | US20050032186 Regulatory zinc finger proteins |
| 02/10/2005 | US20050032185 3-phosphoinositide-dependent protein kinase that phosphorylates and activates protein kinase B alpha; drug target for cancer; drug screening for enzyme inhibitors as anticancer agents |
| 02/10/2005 | US20050032184 Disorazole polyketide synthase encoding polynucleotides |
| 02/10/2005 | US20050032177 Mixture comprising DNA amplification complex for use in inducing mutation in preferential nucleotide sequence; direceted protein synthesis; elucidating structure-function relationships of proteins |
| 02/10/2005 | US20050032176 Modular polyketide synthases with altered activity |
| 02/10/2005 | US20050032175 High affinity fusion proteins and therapeutic and diagnostic methods for use |
| 02/10/2005 | US20050032172 Expression vector comprising nucleotide sequences coding tumor necrosis factor (FTHMA-) and/or axon guidance receptor (T85) for use in identifying modulators for prevention and/or treatment of cell proliferative or neurological disorders |
| 02/10/2005 | US20050032170 Expression vector comprising nucleotide sequences coding native sequence-4 (NS4) for use in identifying modulators for treatment and prevention of obesity, cachexia and anorexia |
| 02/10/2005 | US20050032169 Process for producing isoprenoid compounds by microorganisms and a method for screening compounds with antibiotic or weeding activity |
| 02/10/2005 | US20050032168 17 human secreted proteins |
| 02/10/2005 | US20050032165 Potassium channels, nucleotide sequences encoding them, and methods of using same |
| 02/10/2005 | US20050032161 Novel xanthine phosphoribosyl transferase |
| 02/10/2005 | US20050032159 Method for low-temperature culture of microorganism |
| 02/10/2005 | US20050032158 Using novel g-protein coupled taste receptor (T1R2) as tools in identifying modulators to use as additives which enhance sweetness of foods consumed by animal and humans |
| 02/10/2005 | US20050032156 Identification and characterization of phosphate transporter genes |
| 02/10/2005 | US20050032155 Expression vector comprising nucleotide sequences coding defective receptor protein for use as model in treatment and prevention of convulsive disorders |
| 02/10/2005 | US20050032150 A-beta-peptide screening |
| 02/10/2005 | US20050032145 Spectrophotometric assay; incubating a mixture of said amidotransferase, fructose 6-phosphate, and glutamine to form glutamine-6-phosphate, acetylating to to form N-acetylglucosamine, reacting with Ehrlich's reagent, measuring optical density; use in high throughput microtiter plate analysis |
| 02/10/2005 | US20050032134 Neoplasm-specific polypeptides and their uses |
| 02/10/2005 | US20050032131 Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases |
| 02/10/2005 | US20050032125 Constitutively translocating cell line |
| 02/10/2005 | US20050032123 Oncoprotein protein kinase |
| 02/10/2005 | US20050032113 Membrane protein library for proteome analysis and method for preparing same |
| 02/10/2005 | US20050032112 Preparing transgenic, salt tolerant rice which express sodium transport protein |
| 02/10/2005 | US20050032111 Using intregral membrane protein concentration as diagnostic and/or prognostic indicator of successful pregnancy; in vitro fertilization and reproductive disorders |
| 02/10/2005 | US20050032110 Screening agents capable of modulating cell phenotypes; using nucleotide sequence primer and restriction endonuclease enzyme |
| 02/10/2005 | US20050032109 Polypeptide activator for use as tool in treatment of thrombosis; treatment diagnosis of blood disorders |
| 02/10/2005 | US20050032108 Methods for genome annotation |
| 02/10/2005 | US20050032105 Compositions and methods for using a solid support to purify DNA |